Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 740

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients

Carlson, Linda E, Speca, Michael, Patel, Kamala D, Goodey, Eileen·2004·Psychoneuroendocrinology
DOI 10.1016/s0306-4530(03)00054-4
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0306-4530(03)00054-4

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 66

  1. Andersen, 1994, A biobehavioral model of cancer stress and disease course, Am. Psychol., 49, 389, 10.1037/0003-066X.49.5.389 · DOI · Paper page
  2. Aragona, 1996, Lymphocyte number and stress parameter modifications in untreated breast cancer patients with depressive mood and previous life stress, J. Exp. Ther. Oncol., 1, 354
  3. Bartsch, 1985, Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate: relationship with the pituitary hormones, J. Pineal Res., 2, 121, 10.1111/j.1600-079X.1985.tb00633.x · DOI
  4. Blauer, 1991, Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation, Endocrinology, 129, 3174, 10.1210/endo-129-6-3174 · DOI
  5. Carlson, 1999, Relationships among cortisol (CRT), dehydroepiandrosterone-sulfate (DHEAS), and memory in a longitudinal study of healthy elderly men and women, Neurobiol. Aging, 20, 315, 10.1016/S0197-4580(99)00052-4 · DOI
  6. Cassileth, 1998, Alternative and complementary cancer therapies, Cancer, 77, 1026, 10.1002/(SICI)1097-0142(19960315)77:6<1026::AID-CNCR4>3.0.CO;2-F · DOI
  7. Cassileth, 1985, Psychosocial status of cancer patients and next of kin: normative data from the profile of mood states, J. Psychosoc. Oncol., 3, 99, 10.1300/J077v03n03_08 · DOI
  8. Cos, 1998, Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells, Cancer Res., 58, 4383
  9. Courneya, 2001, Exercise interventions during cancer treatment: biopsychosocial outcomes, Exerc. Sport Sci. Rev., 29, 60
  10. Courneya, 1999, Physical exercise and quality of life following cancer diagnosis: a literature review, Ann. Behav. Med., 21, 171, 10.1007/BF02908298 · DOI · Paper page
  11. Cruess, 1999, Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEAS) and increases in the cortisol/DHEAS ratio and reduces mood disturbance and perceived stress among HIV-seropostive men, Psychoneuroendocrinology, 24, 537, 10.1016/S0306-4530(99)00010-4 · DOI
  12. Cruess, 2000, Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer, Psychosom. Med., 62, 304, 10.1097/00006842-200005000-00002 · DOI · Paper page
  13. Deepak, 1994, Meditation improves clinicoelectroencephalographic measures in drug-resistant epileptics, Biofeedback Self Regul., 19, 25, 10.1007/BF01720668 · DOI
  14. DeFlorio, 1995, Review of depression in cancer: gender differences, Depression, 3, 66, 10.1002/depr.3050030112 · DOI
  15. Derogatis, 1983, The prevalence of psychiatric disorders among cancer patients, J. Am. Med. Assoc., 249, 751, 10.1001/jama.1983.03330300035030 · DOI · Paper page
  16. Dorgan, 1997, Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women, Cancer Epidemiol. Biomarkers Prev., 6, 177
  17. Ernst, 1998, The prevalence of complementary/alternative medicine in cancer: a systematic review, Cancer, 83, 777, 10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O · DOI
  18. Esterling, 1996, Psychosocial modulation of cytokine-induced natural killer cell activity in older adults, Psychosom. Med., 58, 264, 10.1097/00006842-199605000-00010 · DOI
  19. Friedenreich, 2001, Relation between intensity of physical activity and breast cancer risk reduction, Med. Sci. Sports Exerc., 33, 1538, 10.1097/00005768-200109000-00018 · DOI
  20. Glaser, 1992, Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs, J. Behav. Med., 15, 327, 10.1007/BF00844726 · DOI
  21. Gordon, 1990, Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone-sulfate to the risk of developing postmenopausal breast cancer, Cancer Res., 50, 3859
  22. Guazzo, 1996, Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age, J. Clin. Endocrinol. Metab., 81, 3951
  23. Heuser, 1998, Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients, J. Clin. Endocrinol. Metab., 83, 3130, 10.1210/jcem.83.9.5081 · DOI
  24. Hornsby, 1995, Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline, Ann. N. Y. Acad. Sci., 774, 29, 10.1111/j.1749-6632.1995.tb17370.x · DOI
  25. Johannes, 1999, Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women’s Health Study, J. Clin. Epidemiol., 52, 95, 10.1016/S0895-4356(98)00144-9 · DOI
  26. Kailajarvi, 2000, Early effects of adjuvant tamoxifen therapy on serum hormones, proteins and lipids, Anticancer Res., 20, 1323
  27. Kanno, 1997, Effect of restraint stress on immune system and experimental B melanoma metastasis in aged mice, Mech. Ageing Dev., 93, 107, 10.1016/S0047-6374(96)01827-1 · DOI
  28. Keller, 1999, Ilness-related distress: does it mean the same for men and women?, Acta Oncol., 38, 747, 10.1080/028418699432905 · DOI
  29. Kirschbaum, 1994, Salivary cortisol in psychoneuroendocrine research: recent developments and applications, Psychoneuroendocrinology, 19, 313, 10.1016/0306-4530(94)90013-2 · DOI · Paper page
  30. Laakso, 1990, Correlation between salivary and serum melatonin: dependence on serum melatonin levels, J. Pineal Res., 9, 39, 10.1111/j.1600-079X.1990.tb00692.x · DOI
  31. Liebmann, 1997, Melatonin and immune system, Arch. Allergy Immunol., 112, 203, 10.1159/000237455 · DOI
  32. Lissoni, 1997, Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone, Eur. Urol., 31, 178, 10.1159/000474446 · DOI
  33. Lissoni, 1999, Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status, Eur. J. Cancer, 35, 1688, 10.1016/S0959-8049(99)00159-8 · DOI · Paper page
  34. Lissoni, 1999, Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study, J. Pineal Res., 26, 169, 10.1111/j.1600-079X.1999.tb00579.x · DOI
  35. Lonning, 1995, Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients, J. Steroid Biochem. Mol. Biol., 52, 491, 10.1016/0960-0760(94)00189-S · DOI
  36. MacLean, 1994, Altered responses of cortisol, GH, TSH and testosterone to acute stress after four months’ practice of transcendental meditation (TM), Ann. N. Y. Acad. Sci., 746, 381, 10.1111/j.1749-6632.1994.tb39261.x · DOI
  37. Majewska, 1995, Neuronal action of dehydroepiandrosterone: possible roles in brain development, aging, memory and affect, Ann. N. Y. Acad. Sci., 774, 111, 10.1111/j.1749-6632.1995.tb17375.x · DOI
  38. Massion, 1995, Meditation, melatonin and breast/prostate cancer: hypothesis and preliminary data, Med. Hypotheses, 44, 39, 10.1016/0306-9877(95)90299-6 · DOI
  39. Mazat, 2001, Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality, Proc. Natl. Acad. Sci. U.S.A., 98, 8145, 10.1073/pnas.121177998 · DOI
  40. McEwen, 1995, Stress and cognitive function, Curr. Opin. Neurobiol., 5, 205, 10.1016/0959-4388(95)80028-X · DOI · Paper page
  41. McIntyre, 1987, Melatonin rhythm in human plasma and saliva, J. Pineal Res., 4, 177, 10.1111/j.1600-079X.1987.tb00854.x · DOI
  42. Michelson, 2000, Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population, Acta Oncol., 39, 477, 10.1080/028418600750013384 · DOI · Paper page
  43. Morales, 1994, Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age, J. Clin. Endocrinol. Metab., 78, 1360
  44. Mormont, 1997, Circadian-system alterations during cancer processes: a review, Int. J. Cancer, 70, 241, 10.1002/(SICI)1097-0215(19970117)70:2<241::AID-IJC16>3.0.CO;2-L · DOI
  45. Riska, 1999, Mental distress: gender aspects of symptoms and coping, Acta Oncol., 38, 757, 10.1080/028418699432914 · DOI
  46. Schedlowski, 1994, Effects of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients: an exploratory study, Psycho-Oncology, 3, 181, 10.1002/pon.2960030304 · DOI
  47. Schneider, 1995, A randomised controlled trial of stress reduction for hypertension in older African Americans, Hypertension, 26, 820, 10.1161/01.HYP.26.5.820 · DOI · Paper page
  48. Sephton, 2000, Diurnal cortisol rhythm as a predictor of breast cancer survival, J. Natl. Cancer Inst., 92, 944, 10.1093/jnci/92.12.994 · DOI · Paper page
  49. Shirtcliff, 2001, Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results, Psychoneuroendocrinology, 26, 165, 10.1016/S0306-4530(00)00042-1 · DOI · Paper page
  50. Sikes, 1989, Cognitive sequelae of hypothalamic-pituitary-adrenal (HPA) dysregulation in depression, Biol. Psychiatry, 25, 148A, 10.1016/0006-3223(89)91784-8 · DOI
  51. Singh, 1998, A pilot study of cognitive behavioral therapy in fibromyalgia, Altern. Ther. Health Med., 4, 67
  52. Spiegel, 1996, Cancer and depression, Br. J. Psychiatry Suppl., 109, 10.1192/S0007125000298486 · DOI · Paper page
  53. Spiegel, 1998, Effects of psychosocial treatment in prolonging cancer survival may be mediated by neuroimmune pathways, Ann. N. Y. Acad. Sci., 840, 674, 10.1111/j.1749-6632.1998.tb09606.x · DOI
  54. Tamarkin, 1982, Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer, Science, 216, 1003, 10.1126/science.7079745 · DOI
  55. Ticher, 1996, The pattern of hormonal circadian time structure (acrophase) as an assessor of breast-cancer risk, Int. J. Cancer, 65, 591, 10.1002/(SICI)1097-0215(19960301)65:5<591::AID-IJC6>3.0.CO;2-Y · DOI
  56. Tooley, 2000, Acute increases in night-time plasma melatonin levels following a period of meditation, Biol. Psychol., 53, 69, 10.1016/S0301-0511(00)00035-1 · DOI
  57. Touitou, 1996, Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens, Br. J. Cancer, 74, 1248, 10.1038/bjc.1996.524 · DOI
  58. van der Pompe, 1997, Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study, J. Psychosom. Res., 42, 453, 10.1016/S0022-3999(96)00393-5 · DOI
  59. van der Pompe, 1996, Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer, Psychoneuroendocrinology, 21, 361, 10.1016/0306-4530(96)00009-1 · DOI
  60. Vermeulen, 1995, Dehydroepiandrosterone sulfate and aging, Ann. N. Y. Acad. Sci., 774, 121, 10.1111/j.1749-6632.1995.tb17376.x · DOI
  61. Vijayalaxmi, 2002, Melatonin: from basic research to cancer treatment clinics, J. Clin. Oncol., 20, 2575, 10.1200/JCO.2002.11.004 · DOI
  62. Voultsios, 1997, Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin, J. Biol. Rhythms, 12, 457, 10.1177/074873049701200507 · DOI · Paper page
  63. Walton, 1995, Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism, J. Altern. Complement. Med., 1, 263, 10.1089/acm.1995.1.263 · DOI · Paper page
  64. Wolkowitz, 1994, Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids, Psychoneuroendocrinology, 3, 233, 10.1016/0306-4530(94)90064-7 · DOI
  65. Wolkowitz, 1997, DHEA treatment of depression, Biol. Psychiatry, 41, 311, 10.1016/S0006-3223(96)00043-1 · DOI · Paper page
  66. Zabora, 1997, Prevalence of psychological distress among cancer patients across the disease continuum, J. Psychosoc. Oncol., 15, 73, 10.1300/J077v15n02_05 · DOI

Cited by

Metadata

Authors
Carlson, L. E., Speca, M., Patel, K. D., & Goodey, E.
Venue
Psychoneuroendocrinology
Publisher
Elsevier BV
Published
2004-05
Volume
29
Issue
4
Pages
448-474
ISSN
0306-4530 (ISSN-L)
DOI
10.1016/s0306-4530(03)00054-4
OpenAlex
W1989396540
Cited by
740
References
15
FWCI
22.51
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.